Focused radiation after surgery for grade II or returning grade I meningioma
Original title: Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
The trial does not list a phase, so it is early in what we know.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial is testing a short, targeted form of radiation given after meningioma surgery.
Who this trial is for. This trial is for people who had surgery for a grade II meningioma, or a grade I meningioma that came back after getting better. It tests a targeted radiation treatment given in higher doses over a shorter time.
Where it stands. The trial is looking at how safe this radiation is, how well people handle it, and how well it works. Those answers are not in yet. The trial has not reported results.
What this means, and what it doesn't
What it could mean: If this sounds like your situation, you could ask your care team about it. They can tell you if a trial like this makes sense for you and how to find out more.
What it doesn't mean: This does not mean the treatment is proven. A trial is a test, not care your doctor can simply give you. Being in a trial is not a promise that it will help you. It is not a cure.
Source: ClinicalTrials.gov, August 26, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.